HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PETA Applauds Nature’s Gate For Exiting China’s Cosmetics Market

This article was originally published in The Rose Sheet

Executive Summary

Nature’s Gate follows the example of brands including Dermalogica and Pangea Naturals, choosing to close its business in China following talks with PETA, which denounces the country’s animal-testing requirements.

You may also be interested in...



Avon Joins Global #BeCrueltyFree Campaign Amid Natura Deal Talks

The turnaround-minded direct seller confirmed in late March that it was in discussions with Natura about a potential transaction. Natura prides itself on its cruelty-free status, and Avon increasingly seems like it could be a good fit in that regard.

China FDA Draft Rule: No More Animal Tests Needed For Many Cosmetics

Firms that manufacture ordinary-use cosmetics in China would be able to support product safety with non-animal data under draft rules issued by the country's food and drug authority Nov. 5. Among other proposed changes, whitening skin-care products would be reclassified as special-use cosmetics, a move likely influenced by Kao Corporation’s recall of Kanebo brighteners due to widespread adverse reactions.

Victor In China’s Cosmetic-Ingredient Approval Process Tells His Story

Navigating China’s notoriously challenging registration process for new cosmetic ingredients requires a local representative who can respond quickly to CFDA’s questions before the evaluation committee membership changes and sends firms back to square one. A former Symrise exec offers insight into the process and how the supplier successfully won approval for its SymWhite 377 brightening agent.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel